Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1
- PMID: 19845691
- DOI: 10.1111/j.1399-0004.2009.01233.x
Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1
Abstract
Noonan syndrome (NS) and neurofibromatosis type I (NF1) belong to a group of clinically related disorders that share a common pathogenesis, dysregulation of the RAS-MAPK pathway. NS is characterized by short stature, heart defect, pectus deformity and facial dysmorphism, whereas skin manifestations, skeletal defects, Lisch nodules and neurofibromas are characteristic of NF1. Both disorders display considerable clinical variability. Features of NS have been observed in individuals with NF1 -a condition known as neurofibromatosis-Noonan syndrome (NFNS). The major gene causing NFNS is NF1. Rarely, a mutation in PTPN11 in addition to an NF1 mutation is present. We present the clinical and molecular characterization of a family displaying features of both NS and NF1, with complete absence of neurofibromas. To investigate the etiology of the phenotype, mutational analysis of NF1 was conducted, revealing a novel missense mutation in exon 24, p.L1390F, affecting the GAP-domain. Additional RAS-MAPK pathway genes were examined, but no additional mutations were identified. We confirm that NF1 mutations are involved in the etiology of NFNS. Furthermore, based on our results and previous studies we suggest that evaluation of the GAP-domain of NF1 should be prioritized in NFNS.
Similar articles
-
Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.Am J Med Genet A. 2014 Mar;164A(3):579-87. doi: 10.1002/ajmg.a.36313. Epub 2013 Dec 19. Am J Med Genet A. 2014. PMID: 24357598
-
[Developmental manifestation in children with neurofibromatosis type 1].Harefuah. 2010 Jan;149(1):49-52, 61. Harefuah. 2010. PMID: 20422842 Review. Hebrew.
-
Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.Am J Med Genet A. 2009 Jun;149A(6):1263-7. doi: 10.1002/ajmg.a.32837. Am J Med Genet A. 2009. PMID: 19449407
-
Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.Horm Res. 2009;71(4):185-93. doi: 10.1159/000201106. Epub 2009 Mar 4. Horm Res. 2009. PMID: 19258709 Review.
-
Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome.Am J Med Genet. 1998 Jan 23;75(3):265-72. Am J Med Genet. 1998. PMID: 9475595
Cited by
-
Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian girl due to a pathogenic variant in NF1 gene.Hum Genomics. 2023 Feb 20;17(1):12. doi: 10.1186/s40246-023-00460-0. Hum Genomics. 2023. PMID: 36803953 Free PMC article.
-
RASopathy Cohort of Patients Enrolled in a Brazilian Reference Center for Rare Diseases: A Novel Familial LZTR1 Variant and Recurrent Mutations.Appl Clin Genet. 2022 Oct 21;15:153-170. doi: 10.2147/TACG.S372761. eCollection 2022. Appl Clin Genet. 2022. PMID: 36304179 Free PMC article.
-
LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.BMC Med Genomics. 2022 Jul 15;15(1):160. doi: 10.1186/s12920-022-01304-x. BMC Med Genomics. 2022. PMID: 35840934 Free PMC article. Review.
-
A Novel Heterozygous NF1 Variant in a Neurofibromatosis-Noonan Syndrome Patient with Growth Hormone Deficiency: A Case Report.J Clin Res Pediatr Endocrinol. 2023 Nov 22;15(4):438-443. doi: 10.4274/jcrpe.galenos.2022.2021-12-24. Epub 2022 May 31. J Clin Res Pediatr Endocrinol. 2023. PMID: 35633639 Free PMC article.
-
Clinical Characteristics and Mutation Spectrum of Neurofibromatosis Type 1 in 27 Turkish Families.Balkan Med J. 2021 Nov;38(6):365-373. doi: 10.5152/balkanmedj.2021.21006. Balkan Med J. 2021. PMID: 34860164 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
